Search
Search Results
##search.searchResults.foundPlural##
-
A Rare Case of Rosai-Dorfman Disease in an Adult Male Associated with Auto-immune Hemolytic Anemia.
1413PDF: 941HTML: 1668Figure 1: 186 -
ASSESSMENT OF DIAGNOSTIC TECHNIQUES OF URINARY TUBERCULOSIS
2195PDF: 792HTML: 2353Untitled: 222 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2499PDF: 895HTML: 2502 -
-
THE PERFORMANCE OF HOMA 2 COMPARED TO DYNAMIC MARKERS OF INSULIN SECRETION AND SENSITIVITY/RESISTANCE FOR PREDICTING DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β-THALASSEMIA: THE EXPERIENCE OF A SINGLE CENTRE HOMA 2 and DYNAMIC MARKERS OF INSULIN SECRETION FOR PREDICTING DYSGLYCEMIA in TDT
144PDF: 122HTML: 32 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
7163PDF: 4030HTML: 24919 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2722PDF: 967HTML: 583 -
-
Antimicrobial Stewardship in a world racked by conflict and uncertainty: A Call for global resilience AMS in conflict areas
362PDF: 173Html: 47 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3765PDF: 1647HTML: 84 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1755PDF: 1122HTML: 10725Untitled: 199 -
Stroke in a patient with tuberculous meningitis and HIV infection
1714PDF: 830HTML: 1795figure 1: 172 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1250PDF: 941HTML: 314 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
4010PDF: 1325HTML: 2356 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2808PDF: 989HTML: 4718 -
A STUDY ON THE EXPRESSION OF BCR-ABL TRANSCRIPT IN MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL) CASES USING THE REVERSE TRANSCRIPTASE POLYMERASE REACTION ASSAY (RT-PCR) AND ITS CORRELATION WITH HEMATOLOGICAL REMISSION STATUS POST INITIAL INDUCTION THERAPY
1396PDF: 861HTML: 5056INSTITUTE PUBLICATION COMMITTEE APPROVAL: 174 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1344PDF: 752HTML: 360 -
Worldwide distribution of prekallikrein (PK) deficiency: the defect seems mainly concentrated in West African countries and in the United States Worldwide distribution of PK deficiency:
1109PDF: 274HTML: 161 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3308PDF: 1482HTML: 5960Fig1-Ag-Pil: 244Ag-Pil Fig.2: 245 -
GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA
1529PDF: 644HTML: 305 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
2010PDF: 1073HTML: 304 -
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
1470PDF: 856HTML: 1080Untitled: 192 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1864PDF: 838HTML: 10285Figures 1,2,3: 202 -
A MULTICENTER ICET-A STUDY ON AGE AT MENARCHE AND MENSTRUAL CYCLES IN PATIENTS WITH TRANSFUSION-DEPENDENT THALASSEMIA (TDT) WHO STARTED EARLY CHELATION THERAPY WITH DIFFERENT CHELATING AGENTS. Age at menarche and menstrual cycles in patients with transfusion-dependent thalassemia.
824PDF: 546HTML: 123 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2034PDF: 746HTML: 701Table1: patient's characteristics: 163Table 2: profile of each patient: 187 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2917PDF: 1131HTML: 409Preferred Reviewers: 217 -
Idiopathic pulmonary embolism in a case of severe family ANKRD26 thrombocytopenia
2250PDF: 851HTML: 946Patient’s family tree: 185 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3288PDF: 1363HTML: 4148 -
THE TRAGEDY CAUSED BY FAKE ANTIMALARIAL DRUGS
2823PDF: 1098HTML: 1941







